Effects of clusterin over-expression on metastatic progression and therapy in breast cancer.
Flanagan
Louise
L
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.
Whyte
Lorna
L
Chatterjee
Namita
N
Tenniswood
Martin
M
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D051152:Clusterin / Q000096:biosynthesis* / Q000235:genetics; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis; D013629:Tamoxifen / Q000494:pharmacology*; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D023041:Xenograft Model Antitumor Assays
C495242:CLU protein, human; D051152:Clusterin; D014409:Tumor Necrosis Factor-alpha; D013629:Tamoxifen